Monsanto Company – Reaffirms FY12 earnings at Investor Day
Monsanto Company (NYSE:MON). Last Market Price: 73.56, Change: +1.63, % Change: (2.27%). Shares trade in the range of 71.53 – 73.80 dollars. It has a market capitalization of 39.34B dollars, making it a Large Cap Stock and has 534.74M outstanding shares. The company has a beta of 0.95, indicating, the stock to be less volatile than the market. As per the most recent quarterly report, the net income per share (EPS) is 2.91; P/E of 25.24 indicating high expected future growth in earnings. It operates in Basic Materials sector and belongs to Chemical Manufacturing industry. Percentage shares held by institutional investors is 82%. The company has a 52 week Price range (low – high) of $ 57.56 – 78.71. Average volumes of shares traded daily are 5,460,000. Volume traded in the last session was at 2,070,000, 0.38 times the average volume.
- At its Investor Day, company reaffirms FY12 EPS of $3.34-3.44
- Company sees Q1 EPS at high end of $0.10-0.15
For Q3 (Aug ’11), It had a Net profit margin of -4.32%, an Operating margin of -3.16%. Other Key stats and ratios are : Return on average assets of -1.95%, Return on average equity of -3.80%. The organization has an employee strength of 21,400
Consensus Recommendation is a Outperform.
Estimate for sales for the Quarter Ending Nov-11 show a mean of 2,000.27 million dollars, an estimate high of 2,209.50 million dollars and an estimate low of 1,920.00 million dollars. A year ago the figures stood at 1,985.00 million dollars.
Estimate for sales for the Quarter Ending Feb-12 show a mean of 4,531.78 million dollars, an estimate high of 4,667.12 million dollars and an estimate low of 4,373.93 million dollars. A year ago the figures stood at 4,471.50 million dollars.
Estimate for EPS for the Quarter Ending Nov-11 show a mean of 0.12 dollars, an estimate high of 0.15 dollars and an estimate low of 0.08 dollars. A year ago the figures stood at 0.05 dollars.
Estimate for EPS for the Quarter Ending Feb-12 show a mean of 2.11 dollars, an estimate high of 2.21 dollars and an estimate low of 1.95 dollars. A year ago the figures stood at 2.18 dollars.
Sales for Quarter Ending Aug-11 was estimated at 1,802.62 million dollars, however the actual sales figure stood at 2,247.00 million dollars, 444.38 million dollars more than estimates.
Sales for Quarter Ending May-11 was estimated at 3,362.40 million dollars, however the actual sales figure stood at 3,590.00 million dollars, 227.6 million dollars more than estimates.
Post Written By: Ed Liston
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing in his yacht. |